论文部分内容阅读
目的:观察炎琥宁联合阿昔洛韦治疗带状疱疹临床疗效。方法:88例带状疱疹患者随机分为两组,炎琥宁与阿昔洛韦合用为联合组,单用阿昔洛韦为对照组,于治疗后30 d观察记录治疗效果。结果:联合用药组与对照组比较在痊愈率及后遗神经痛发生率均有统计学差异,两组均无发生不良反应。结论:炎琥宁联合阿昔洛韦治疗带状疱疹疗效好,缩短病程并能降低后遗神经痛的发生,值得临床上应用。
Objective: To observe the clinical efficacy of Yan Hu Ning combined with acyclovir in the treatment of shingles. Methods: A total of 88 patients with shingles were randomly divided into two groups. Yanhuxing combined with acyclovir for the combined group, and acyclovir alone as the control group. The therapeutic effect was recorded 30 days after treatment. Results: There was a significant difference between the combination group and the control group in the cure rate and the incidence of post-nociceptive neuralgia, with no adverse reactions in both groups. Conclusion: Yan Hu Ning combined with acyclovir treatment of herpes zoster good curative effect, shorten the course of the disease and reduce the incidence of post-natal neuralgia, is worth clinical application.